Safety and tolerability of a short ragweed sublingual immunotherapy tablet

Annals of Allergy, Asthma and Immunology

Volumn 113, Issue 1, 2014, Pages 93-100.e3

  Nolte, Hendrik ^a   Amar, Niran ^b   Bernstein, David I ^c   Lanier, Bobby Q ^d   Creticos, Peter ^e   Berman, Gary ^f   Kaur, Amarjot ^a   Hébert, Jacques ^g   Maloney, Jennifer ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Allergy and Asthma Research Institute   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d North Texas Institute for Clinical Trials   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Allergy and Asthma Specialists   (United States)

^g Centre de Recherche Appliquée en Allergie de Québec   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; DIPHENHYDRAMINE; METHYLPREDNISOLONE; MK 3641; PLACEBO; RAGWEED ANTIGEN; SALBUTAMOL; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AIRWAY OBSTRUCTION; ALLERGY; ANALYSIS; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; APPLICATION SITE PRURITUS; APPLICATION SITE REACTION; ARTICLE; ASTHMA; BLURRED VISION; CONTROLLED STUDY; COUGHING; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; DRUG SAFETY; DRUG SELF ADMINISTRATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPHAGIA; DYSPNEA; EAR PRURITUS; FAINTNESS; FEMALE; GLOSSODYNIA; HUMAN; HYPESTHESIA; LIP DISEASE; LIP SWOLLEN; LUMP THROAT; MAJOR CLINICAL STUDY; MALE; MOUTH DISCOMFORT; MOUTH EDEMA; MULTICENTER STUDY; NAUSEA; OCULAR PRURITUS; ORAL HYPOESTHESIA; ORAL PARESTHESIA; ORAL PRURITUS; OROPHARYNX PAIN; PHARYNGEAL PRURITUS; PHARYNX DISEASE; PHARYNX EDEMA; PHASE 3 CLINICAL TRIAL; POOLED ANALYSIS; PRIORITY JOURNAL; PRURITUS; RAGWEED; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SALIVATION; SHORT RAGWEED; STOMATITIS; SUBLINGUAL IMMUNOTHERAPY; THORAX PAIN; THROAT DISEASE; THROAT IRRITATION; THROAT SWOLLEN; THROAT TIGHTNESS; TONGUE SWELLING; TREATMENT DURATION; TREATMENT RESPONSE; URTICARIA; XEROSTOMIA;

ADMINISTRATION, SUBLINGUAL; ADULT; ALLERGENS; ANTIGENS, PLANT; BIOMARKERS, PHARMACOLOGICAL; CONJUNCTIVITIS, ALLERGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PLANT EXTRACTS; RHINITIS, ALLERGIC, SEASONAL; SUBLINGUAL IMMUNOTHERAPY; TABLETS;

EID: 84903150563     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2014.04.018     Document Type: Article

References (20)

1. S.J. Arbes Jr., P.J. Gergen, L. Elliott, and D.C. Zeldin Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey J Allergy Clin Immunol 116 2005 377 383 (Pubitemid 41096546)
2. M. Chan-Yeung, N.R. Anthonisen, and M.R. Becklake et al. Geographical variations in the prevalence of atopic sensitization in six study sites across Canada Allergy 65 2010 1404 1413
3. 2LEN study suggests increasing prevalence Allergy 64 2009 664 665
4. M. Gaudeul, T. Giraud, L. Kiss, and J.A. Shykoff Nuclear and chloroplast microsatellites show multiple introductions in the worldwide invasion history of common ragweed, Ambrosia artemisiifolia PLoS One 6 2011 e17658
5. L. Cox, H. Nelson, and R. Lockey et al. Allergen immunotherapy: a practice parameter third update J Allergy Clin Immunol 127 suppl 2011 S1 S55
6. G.W. Canonica, J. Bousquet, and T. Casale et al. Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009 Allergy 64 2009 1 59
7. D.N. Jourdy, and W.R. Reisacher Factors affecting time required to reach maintenance dose during subcutaneous immunotherapy Int Forum Allergy Rhinol 2 2012 294 299
8. P. Moingeon, and L. Mascarell Induction of tolerance via the sublingual route: mechanisms and applications Clin Dev Immunol 2012 2012 623474
9. J. Dretzke, A. Meadows, and N. Novielli et al. Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison J Allergy Clin Immunol 131 2013 1361 1366
10. A.S. Nayak, G.J. Atiee, E. Dige, J. Maloney, and H. Nolte Safety of ragweed sublingual allergy immunotherapy tablets in adults with allergic rhinoconjunctivitis Allergy Asthma Proc 33 2012 404 410
11. H. Nolte, J. Hébert, and G. Berman et al. Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults Ann Allergy Asthma Immunol 110 2013 450 456.e4
12. P.S. Creticos, J. Maloney, and D.I. Bernstein et al. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults J Allergy Clin Immunol 131 2013 1342 1349.e6
13. H.A. Sampson, A. Muñoz-Furlong, and R.L. Campbell et al. Second symposium on the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium J Allergy Clin Immunol 117 2006 391 397 (Pubitemid 43190153)
14. 2LEN and AllerGen) Allergy 63 2008 8 160 (Pubitemid 351357811)
15. A. Iglesias-Cadarso, and P. Hernandez-Weigand Risk factors for systemic reactions to allergen immunotherapy Curr Opin Allergy Clin Immunol 11 2011 579 585
16. G. Passalacqua, and G.W. Canonica Specific immunotherapy in asthma: efficacy and safety Clin Exp Allergy 41 2011 1247 1255
17. C. André, M. Perrin-Fayolle, and M. Grosclaude et al. A double-blind placebo-controlled evaluation of sublingual immunotherapy with a standardized ragweed extract in patients with seasonal rhinitis. Evidence for a dose-response relationship Int Arch Allergy Immunol 131 2003 111 118 (Pubitemid 36735213)
18. T. Bowen, J. Greenbaum, and Y. Charbonneau et al. Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis Ann Allergy Asthma Immunol 93 2004 425 430 (Pubitemid 39507708)
19. D. Skoner, D. Gentile, and R. Bush et al. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen J Allergy Clin Immunol 125 2010 660 666
20. P.S. Creticos, R.E. Esch, and P. Couroux et al. Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis J Allergy Clin Immunol 133 2014 751 758